Novo Nordisk launched the pill version of its popular GLP-1 weight loss drug Wegovy in the US on Monday, marking a new era in obesity treatment. The debut of the medication, the first of its kind, is set to accelerate a price war, given that it is priced significantly lower than the… This story appeared on semafor.com , 2026-01-05 22:26:43.
Author: semafor.com
Published at: 2026-01-05 22:57:55
Still want to read the full version? Full article
